Exagen Inc. ( XGN) - Stock Earnings
XGN Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Aug. 4, 2026, midnight | — / — | — | — / — | — |
XGN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -7.1 million USD | 17.2 million USD |
| 2025Q4 | -4.7 million USD | 16.6 million USD |
| 2026Q1 | -4.0 million USD | 17.3 million USD |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
XGN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -23.7 million USD | 52.5 million USD |
| 2024 | -15.1 million USD | 55.6 million USD |
| 2025 | -20.0 million USD | 66.6 million USD |
| 2026 Est. | — | — |
XGN
Price: $4.86
52 week price:
Earnings Per Share: -0.90 USD
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Volume: 10300
Market Capitalization: 109.7 million